Culturally Adapted CMAP Plus LTP for Refugee Mothers with History of Self-harm in Pakistan

December 5, 2024 updated by: Pakistan Institute of Living and Learning

Feasibility Study of a Culturally Adapted Manual Assisted Brief Psychological Intervention (CMAP) Plus Learning Through Play (LTP) for Refugee Mothers with History of Self-harm in Pakistan

Objectives:

  • To asses the feasibility and acceptability of a culturally adapted manual assisted brief psychological intervention (CMAP) plus Learning through Play (LTP) for refugee mothers with history of self-harm having children 0-33 months. (Integrated intervention called CMAP Plus)
  • To assess if CMAP Plus will reduce the repetition of self-harm in refugee mothers having children aged between 0-33 months.
  • To determine if the intervention improves infant development and maternal attachment.
  • To explore participants experiences with the intervention.

Study design and setting:

This will be a feasibility cluster randomized control trial (cRCT) of culturally adapted CMAP Plus LTP intervention with refugee mothers from Quetta and Peshawar, Pakistan.

Sample size:

We aim to recruit a sample of 80 refugee mothers in the study.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Mental health of refugees particularly mothers living in camps or in conflict areas is one of the most important issues needing special attention and intervention. Culturally adapted Manual Assisted brief Psychological intervention (CMAP) utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice in reducing repetition of self-harm in people who had recently self-harmed. Similarly, LTP programme promotes child health by supporting attuned interaction between mother and child, increasing maternal awareness of the physical and emotional needs of young children, and encouraging nurture and attachment. The CMAP plus LTP intervention may contribute significantly to the evidence base of addressing mental health of refugee mothers. This study aims to evaluate whether CMAP Plus LTP is feasible, acceptable for this population and helpful to reduce the repetition of self-harm and improve child development among refugee mothers with a history of self-harm. Eligible consented participants will complete the baseline assessments using structured questionnaires. Unit of randomization will be the Union Council. Uniion councils have been slected by the research team through consultations with community advisory committees from both sites. Selected UCs will be randomized into two study arms: 1) C-MAP plus LTP added to treatment as usual and 2) Treatment as usual (TAU) alone. Participants in intervention arm will receive 10 individual sessions of CMAP plus LTP intervention for a period of 12 weeks. All sessions will be delivered by female therapists trained in CMAP Plus. Participants in TAU alone group will receive routine care that includes routine follow up by Community Health Workers (CHWs) in Pakistan. Assessments will be carried out at baseline, and completion of the intervention at 12th week (after intervention). All assessments will be rater-blind (done by independent RAs (female), not involved in delivering the intervention sessions). After post-assessments, a purposefully selected subset (stratified by age) of participants will be invited for qualitative interviews (n = up to 15 interviews) to explore their experiences and satisfaction with the intervention. On average, interviews will last for 60-90 minutes.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Balochistan
      • Quetta, Balochistan, Pakistan, 87300
        • Community settings
    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Community settings

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years and above refugee mothers with children aged between 0-33 months.
  • History of self-harm.
  • Resident in the study site.
  • Capacity to provide informed consent.
  • Available for the duration of the study.

Exclusion Criteria:

  • Unable to provide consent due to severe mental or physical illness.
  • Unlikely to be available for the entire duration of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CMAP Plus LTP added to TAU

C-MAP is a manual assisted intervention based on the principles of CBT which is focused on evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking, and relapse prevention strategies. As family conflicts are a common issue with this group one session is focused on the use of culturally sensitive training in assertiveness and conflict management. The LTP is a community-based parenting intervention designed to deal with early child development. The central feature of the LTP intervention is a pictorial calendar devised for parents which depicts eight successive stages of child development from birth to 3 years along with illustrations of parent-child play and other activities that promote parental involvement, learning, and attachment.

This will be added to Treatment as Usual

The LTP Plus CMAP intervention will be delivered for a period of 12 weeks, including 8 weekly sessions and 2 sessions fortnightly. First 6 sessions will be for a duration of 60-90 minutes and remaining 4 sessions will take approximately 50-60 minutes. All sessions will be delivered by female therapists trained in CMAP and LTP intervention.
No Intervention: TAU alone
TAU alone will include routine follow up by Community Health Workers (CHWs) in Pakistan. Their work includes assisting with all aspects of maternal, new-born and childcare. Participants in treatment as usual arm will receive routine care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility measure
Time Frame: From baseline to 12th week (at the end of intervention)
The feasibility will be determined by collating data on recruitment and retention rates. The success criterion of feasibility will be to recruit > 50% of eligible participants.
From baseline to 12th week (at the end of intervention)
Acceptability measure
Time Frame: From baseline to 12th week (at the end of intervention)
The intervention acceptability will be assessed using data on attendance. Criterion for acceptability is a mean attendance rate of >70% of at least 7 sessions.
From baseline to 12th week (at the end of intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suicide Attempt Self-Injury Interview
Time Frame: From baseline to 12th week
Repetition rate of self-harm at 3 months after randomisation as measured by adapted Suicide Attempt Self-Injury Interview. The questionnaire records self-harm events by severity and chronological order.
From baseline to 12th week
Beck Scale for Suicide Ideation
Time Frame: Change in problem scores from baseline to 12th week
This is a 19-item instrument for detecting and measuring the current intensity of the patients' specific attitudes, behaviours, and specificity of a patient's thoughts to kill him/herself during the past week.
Change in problem scores from baseline to 12th week
Beck Depression Inventory
Time Frame: Change in problem scores from baseline to 12th week
This is a 21 items scale measuring symptoms of depression. Higher scores on the scale indicate greater severity of depression.
Change in problem scores from baseline to 12th week
Beck Hopelessness Scale
Time Frame: Change in problem scores from baseline to 12th week
This instrument is designed to measure three aspects of hopelessness, feelings about the future, loss of motivation and expectations.
Change in problem scores from baseline to 12th week
Generalized Anxiety Disorder
Time Frame: Change in problem scores from baseline to 12th week
This is a 7-item scale used to screen for and measure severity of Generalized Anxiety Disorder.
Change in problem scores from baseline to 12th week
Assessment of the growth and development of children
Time Frame: Change from baseline to 12th week
Anthropometric measures of child growth will be collected through measuring children's height, weight and head circumference
Change from baseline to 12th week
Ages and Stages Questionnaire and ASQ Socio-emotional Scales
Time Frame: Change from baseline to 12th week
Ages and Stages Questionnaire and ASQ Socio-emotional scales will be used to measure child development. Parents will report on their child's communication, gross motor, fine motor, problem solving and personal-social development at different time points.
Change from baseline to 12th week
Coping resource inventory
Time Frame: Change from baseline to 12th week
Coping resource inventory will assess the coping resources to manage stress available to an individual.
Change from baseline to 12th week
Problem Solving Inventory
Time Frame: Change in problem scores from baseline to 12th week
The Problem-Solving Inventory assesses an individual's awareness and evaluation of his or her problem-solving abilities or styles. The problem-solving Inventory is a self-report measure, and thus assesses perceptions of problem solving as opposed to actual problem-solving skills.
Change in problem scores from baseline to 12th week
Infant Development Questionnaire
Time Frame: Change from baseline to 12th week
Infant Development Questionnaire is a 20-item questionnaire of paternal knowledge and expectations for child development in the first three years.
Change from baseline to 12th week
Parenting Stress Index - Short Form
Time Frame: Change from baseline to 12th week
Parents rated 36 item scale on five-point scale (1-5). The scale consists of three subscales: (1) Parenting Distress, (2) Difficult Child Characteristics, and (3) Dysfunctional Parent-Child Interaction.
Change from baseline to 12th week
Multidimensional Scale of Perceived Social Support
Time Frame: Change from baseline to 12th week
This brief scale will assess perceived social support.
Change from baseline to 12th week
Euro-Qol-5 Dimensions scale
Time Frame: Change in problem scores from baseline to 12th week
Health-related quality of life will be measured using the Euro-Qol-5 Dimensions scale. This is a standardized instrument that measures five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each scored from 1 to 3 indicating "no problem" to "severe problems".
Change in problem scores from baseline to 12th week
Client Service Receipt Inventory
Time Frame: Change from baseline to 12th week
This inventory will collect information about the use of other health services (including the informal sector faith healers/Imams) using CSRI based on our previous work in Pakistan
Change from baseline to 12th week
Client Satisfaction Questionnaire
Time Frame: Change from baseline to 12th week
The participants will rate their satisfaction with treatment using the Client Satisfaction Questionnaire.
Change from baseline to 12th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Nasim Chahudhry, Pakistan Institute of Living and Learning
  • Principal Investigator: Nusrat Husain, University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

December 15, 2023

Study Completion (Actual)

December 1, 2024

Study Registration Dates

First Submitted

December 11, 2021

First Submitted That Met QC Criteria

December 11, 2021

First Posted (Actual)

December 28, 2021

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SAHAR M-CMAP Plus LTP-002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Development

Clinical Trials on CMAP Plus LTP

Subscribe